Human Xtensions Ltd.

Tel Aviv Stock Exchange HUMX.TA

Human Xtensions Ltd. Return on Equity (ROE) for the year ending December 31, 2023: -140.33%

Human Xtensions Ltd. Return on Equity (ROE) is -140.33% for the year ending December 31, 2023, a -94.42% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Human Xtensions Ltd. Return on Equity (ROE) for the year ending December 31, 2022 was -72.18%, a -40.71% change year over year.
  • Human Xtensions Ltd. Return on Equity (ROE) for the year ending December 31, 2021 was -51.30%, a -167.48% change year over year.
  • Human Xtensions Ltd. Return on Equity (ROE) for the year ending December 31, 2020 was -19.18%, a 92.03% change year over year.
  • Human Xtensions Ltd. Return on Equity (ROE) for the year ending December 31, 2019 was -240.60%.
Key data
Date Return on Equity (ROE) Return on Capital Employed (ROCE) Interest Coverage Ratio Debt to Equity Ratio
Market news
Tel Aviv Stock Exchange: HUMX.TA

Human Xtensions Ltd.

CEO Dr. Tami Frenkel
IPO Date Dec. 2, 2020
Location Israel
Headquarters Meir Ariel 4
Employees 50
Sector Health Care
Industries
Medical Instruments
Description

Human Xtensions Ltd. develops, manufactures, markets and sells a modular medical device for minimally invasive surgical operations. It offers HandX, a handheld electromechanical device for use in laparoscopic procedures; Fenestrated Grasper; Monopolar Hook; and Needle Holder. The company was incorporated in 2012 and is based in Netanya, Israel.

StockViz Staff

January 15, 2025

Any question? Send us an email